The global oligonucleotide synthesis market size is expected to reach USD 19.64 Billion by 2028 and register a CAGR of 17.9%, according to the latest report by Reports and Data. Key factors such as advancements in healthcare and biotechnology sectors, rising government funding, and expansion of manufacturing unit owing to increasing demand for oligonucleotides are driving global market revenue growth.
Oligonucleotide synthesis is a chemical synthesis process of short nucleic acid fragments, widely used in various laboratory procedures to develop customized oligonucleotides of desired sequence. Synthetic oligonucleotides are also used in clinical settings to detect autoimmune antibodies. Advancements in synthesis techniques, increasing cases of various neurological and infectious diseases, and rising demand for oligonucleotides in various application settings such as research, drug discovery, synthetic biology, and diagnosis is boosting global market growth. Increasing government investments for research projects in genomics and synthetic biology and rising focus on personalized medicine are also fueling global market growth. In addition, increasing investments by market players and high demand for oligonucleotide synthesis technologies by private and public firms for ongoing research is further fueling market growth.
However, unavailability of sufficient funding in research and development sector especially in developing countries, and complexities related to therapeutic oligos are key restraints expected to hamper global market growth in the coming years.
Some key highlights in the report:
Competitive Landscape:
The report also focuses on details of each market player including its global position, financial standing, revenue generation, company overview, and product & service portfolio. The Oligonucleotide Synthesis market is extremely competitive and consists of several key players at the regional and global levels. Key players are focused on adopting various strategies such as new product launches, mergers and acquisitions, investments in R&D, partnerships, joint ventures, and collaborations to strengthen their market position and enhance their product portfolio.
Leading companies operating in the market are:
Agilent Technologies, Inc, ATDBio Ltd., Bio-Synthesis, Inc., BioAutomation Corporation, Thermo Fischer, Scientific, Merck KGaA, LGC Biosearch Technologies, Biogen International, Sarepta Therapeutics, Eurofins Genomics, Eurogentec, GeneDesign, Inc., GE Healthcare, and GenScript, Inc.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/946
The report also offers detailed insights about market segmentation based on type, application and regional bifurcation:
Oligonucleotide Synthesis Market Segmentation:
Product Outlook (Revenue, USD Billion, 2018 – 2028)
Application Outlook (Revenue, USD Billion, 2018 – 2028)
End-Use Outlook (Revenue, USD Billion, 2018 – 2028)
Regional Outlook:
Some essential purposes of the Oligonucleotide Synthesis market research report:
Thank you for reading the report. Kindly note that we also offer customized reports according to the client’s requirements. Contact us to know more about the customization feature and our team will provide you with the best-customized report.
Explore More Industry Research by Reports and Data:
Acute Lymphoblastic Leukemia Drug Market @ https://www.reportsanddata.com/report-detail/acute-lymphoblastic-leukemia-drug-market
Bovine Vaccines Market @ https://www.reportsanddata.com/report-detail/bovine-vaccines-market
Histoplasmosis Treatment Market @ https://www.reportsanddata.com/report-detail/histoplasmosis-treatment-market
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.
Media ContactCompany Name: Reports and DataContact Person: John WatsonEmail: Send EmailPhone: +1-212-710-1370Address:40 Wall St. 28th floor City: New York CityState: NY 10005Country: United StatesWebsite: https://www.reportsanddata.com/report-detail/global-oligonucleotide-synthesis-market